Kurt R. Stenmark

Monocytes and interstitial macrophages contribute to hypoxic pulmonary hypertension

Pathology and pathobiology of pulmonary hypertension: current insights and future directions

Digital Spatial Profiling Identifies Distinct Molecular Signatures of Vascular Lesions in Pulmonary Arterial Hypertension

Classical dendritic cells contribute to hypoxia‐induced pulmonary hypertension

Repetitive <i>schistosoma</i> exposure causes perivascular lung fibrosis and persistent pulmonary hypertension

Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: a global perspective

Abstract 9804: Overexpression of Pericyte Hif2a Exacerbates Hypoxia Induced Pulmonary Hypertension and Right Ventricular Hypertrophy

Publisher Correction: Stable isotope metabolomics of pulmonary artery smooth muscle and endothelial cells in pulmonary hypertension and with TGF-beta treatment

Interstitial macrophage-derived thrombospondin-1 contributes to hypoxia-induced pulmonary hypertension

Pre-clinical assessment of a water-in-fluorocarbon emulsion for the treatment of pulmonary vascular diseases

Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives

Identification of MicroRNA-124 as a Major Regulator of Enhanced Endothelial Cell Glycolysis in Pulmonary Arterial Hypertension via PTBP1 (Polypyrimidine Tract Binding Protein) and Pyruvate Kinase M2

Transcription Factors, Transcriptional Coregulators, and Epigenetic Modulation in the Control of Pulmonary Vascular Cell Phenotype: Therapeutic Implications for Pulmonary Hypertension (2015 Grover Conference Series)

Unique Aspects of the Developing Lung Circulation: Structural Development and Regulation of Vasomotor Tone

MicroRNA-143 Activation Regulates Smooth Muscle and Endothelial Cell Crosstalk in Pulmonary Arterial Hypertension

Chemotherapy-Induced Pulmonary Hypertension

Anticipated Classes of New Medications and Molecular Targets for Pulmonary Arterial Hypertension